Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX)
CUSIP: 20454B104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 180,577,721
- Total 13F shares
- 101,374,021
- Share change
- +1,356,907
- Total reported value
- $146,996,022
- Price per share
- $1.45
- Number of holders
- 92
- Value change
- +$1,180,763
- Number of buys
- 51
- Number of sells
- 23
Quarterly Holders Quick Answers
What is CUSIP 20454B104?
CUSIP 20454B104 identifies CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 20454B104:
Top shareholders of CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
22,362,850
|
$41,147,644 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
13D/G
|
Company · Adage Capital Management, L.P. |
4.4%
from 13D/G
|
11,130,000
|
$20,479,200 | — | 30 Sep 2024 | |
| Blackstone Inc. |
13F
|
Company |
5.6%
|
10,025,151
|
$18,446,278 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3.8%
|
6,820,452
|
$12,549,631 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
3.1%
|
5,641,894
|
$10,381,085 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
3.1%
|
5,629,239
|
$10,357,800 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
4,283,186
|
$7,881,062 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
2.3%
|
4,136,273
|
$7,610,743 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
2%
|
3,556,023
|
$6,543,082 | — | 30 Sep 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.6%
|
2,879,712
|
$5,298,670 | — | 30 Sep 2024 | |
| Vered Bisker-Leib |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
4,877,551
mixed-class rows
|
$4,530,418 | — | 08 Feb 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
2,309,778
|
$4,251,040 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,863,977
|
$3,429,718 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1%
|
1,843,286
|
$3,363,997 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,812,995
|
$3,335,911 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.86%
|
1,557,630
|
$2,866,039 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.47%
|
844,389
|
$1,553,676 | — | 30 Sep 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.28%
|
500,000
|
$920,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.21%
|
377,887
|
$695,312 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
371,129
|
$682,877 | — | 30 Sep 2024 | |
| CM Management, LLC |
13F
|
Company |
0.17%
|
310,000
|
$570,400 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
304,504
|
$560,287 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
286,191
|
$526,591 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.13%
|
232,049
|
$426,970 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
231,934
|
$426,758 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
222,600
|
$409,584 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
193,259
|
$355,597 | — | 30 Sep 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.1%
|
180,000
|
$331,200 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
170,245
|
$313,251 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
169,403
|
$311,702 | — | 30 Sep 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
141,611
|
$260,564 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
125,294
|
$230,535 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.06%
|
116,882
|
$215,063 | — | 30 Sep 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.05%
|
97,931
|
$180,193 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
86,400
|
$158,976 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
86,164
|
$158,542 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
82,717
|
$152,200 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
74,281
|
$136,677 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
73,487
|
$135,216 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.04%
|
65,922
|
$121,000 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
65,400
|
$120,336 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
64,226
|
$118,176 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
55,958
|
$102,963 | — | 30 Sep 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
54,532
|
$100,339 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
50,000
|
$92,000 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
46,822
|
$86,152 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
44,464
|
$81,814 | — | 30 Sep 2024 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
43,465
|
$79,976 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
42,671
|
$78,515 | — | 30 Sep 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
38,665
|
$71,000 | — | 30 Sep 2024 |
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q4 2024
As of 31 Dec 2024,
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,374,021 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Blackstone Inc., MPM BIOIMPACT LLC, Enavate Sciences GP, LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., TANG CAPITAL MANAGEMENT LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, and FMR LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
79
Q4 2024 holders
92
Holder diff
13
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.